2020
DOI: 10.1186/s41983-020-00237-5
|View full text |Cite
|
Sign up to set email alerts
|

Gabapentin as an adjuvant therapy to splinting in carpal tunnel syndrome (CTS): a systematic review and meta-analysis of randomized controlled trials

Abstract: Background Carpal tunnel syndrome (CTS) is a common upper limb entrapment neuropathy; severe cases are treated surgically and mild to moderate can be managed conservatively. The purpose of this systematic review and meta-analysis was to define the efficacy of gabapentin as an adjuvant to splinting in the treatment of mild to moderate CTS. Methods A systematic search through 13 databases, randomized clinical trials (RCTs) reporting the use of gabapentin with splinting in CTS were included and analyzed. Resu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…39 A study review recommends no significant advantage of gabapentin use for symptomatic relief or power strength improvement in mild-to-moderate CTS patients. 40 Pregabalin has been recommended as first-and/or second-line drug for neuropathic pain in several guidelines. Pregabalin is started at 150 mg daily and titrated up to the maintenance daily dose range.…”
Section: Pharmacological Managementmentioning
confidence: 99%
“…39 A study review recommends no significant advantage of gabapentin use for symptomatic relief or power strength improvement in mild-to-moderate CTS patients. 40 Pregabalin has been recommended as first-and/or second-line drug for neuropathic pain in several guidelines. Pregabalin is started at 150 mg daily and titrated up to the maintenance daily dose range.…”
Section: Pharmacological Managementmentioning
confidence: 99%